Tech Company Financing Transactions
ARCA Discovery Funding Round
ARCA Discovery closed a $15 million Series A investment round on 3/2/2006. Investors included Atlas Venture, Boulder Ventures and FirstMark Capital.
Transaction Overview
Company Name
Announced On
3/2/2006
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Atlas Venture (Lead Investor) (Jean-François Formela)
Boulder Ventures (Kyle Lefkoff)
Proceeds Purpose
This round of financing allows us to complete the filing of a New Drug Application (NDA) for bucindolol, the first genetically-targeted cardiovascular drug.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8001 Arista Pl. 430
Broomfield, CO 80021
USA
Broomfield, CO 80021
USA
Phone
Website
Email Address
Overview
ARCA Discovery, Inc., a privately held biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Bristow
Chief Financial Officer
Patrick Wheeler
VP - General Counsel
Christopher Ozeroff
Browse more venture capital transactions:
Prev: 3/1/2006: Oneida Broadband venture capital transaction
Next: 3/6/2006: OpTier venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs